Spunweb Nonwoven IPO GMP Today: Subscription, Price, Listing

Spunweb Nonwoven IPO GMP surges 36 percent as subscription hits record highs. Get latest updates on price, allotment, and listing details.

Sachin Kumar

5 days ago

Spunweb Nonwoven IPO GMP Today

Spunweb Nonwoven IPO GMP Surges 36 Percent: What Investors Need to Know Today

The Indian IPO market is abuzz again, and the Spunweb Nonwoven IPO is grabbing headlines. With a grey market premium climbing to Rs. 35 and retail subscriptions exceeding expectations, investors are closely watching this SME offering. Here's a comprehensive, real-time breakdown of the IPO's current status, financials, and market momentum.

Subscription Status and GMP Overview

  • IPO Open Date: July 14, 2025

  • IPO Close Date: July 16, 2025

  • Issue Size: Rs. 60.98 crore (entirely fresh issue of 63.52 lakh shares)

  • Price Band: Rs. 90 to Rs. 96 per share

  • Lot Size: 1,200 shares (minimum investment Rs. 2,16,000)

  • GMP Today: Rs. 35 (36.46 percent premium over issue price)

  • Expected Listing Price: Rs. 131

  • Subscription Status (Day 1):

    • Retail Investors: 10.47x

    • Non-Institutional Investors: 5.99x

    • Overall: 6.52x

High grey market premium and retail demand highlight strong investor interest in this SME listing.

Company Overview: Spunweb Nonwoven Ltd

Established in 2015 in Rajkot, Gujarat, Spunweb Nonwoven Ltd specializes in the production of polypropylene spunbond nonwoven fabrics. These products cater to diverse industries, including:

  • Hygiene and personal care: diapers, sanitary napkins

  • Medical supplies: face masks, surgical gowns, PPE kits

  • Agriculture and packaging

  • Construction and industrial applications

The company boasts an installed production capacity of 32,640 metric tons and services over 485 domestic clients. It also exports to more than 20 countries, such as the United States, Italy, Egypt, UAE, and Saudi Arabia.

Why This Is Trending Right Now

The IPO's sharp rise in grey market premium and high subscription numbers are creating real momentum. Here’s why:

  • Significant GMP Jump: Rs. 35 premium signals robust secondary market expectations

  • Massive Retail Response: First day subscription hit 10.47x in the retail category

  • Sector Momentum: Post-COVID surge in demand for nonwoven fabrics used in hygiene and medical sectors

  • Financial Growth: FY24 to FY25 saw a 47 percent revenue increase and nearly doubled PAT

  • Pre-IPO Anchor Investment: Rs. 17.3 crore secured from anchor investors before opening

  • Upcoming Listing: Scheduled for NSE SME on July 21, 2025

These factors are aligning to position Spunweb as one of the most anticipated SME IPOs this year.

IPO Objectives and Fund Utilization

The company will deploy the IPO funds for:

  • Augmenting working capital

  • Investing in its wholly owned subsidiary SIPL

  • Repaying existing debt

  • General corporate purposes

These plans reflect Spunweb’s vision for scalable growth and financial stability.

Real-Time Investor Sentiment

Search patterns across major cities in India—including Mumbai, Delhi, Bengaluru—show a sharp rise in queries related to Spunweb Nonwoven IPO GMP. Financial news outlets and investor forums are actively discussing its grey market trends, listing projections, and retail subscription momentum.

Frequently Asked Questions

What is the GMP of Spunweb Nonwoven IPO today?

The GMP stands at Rs. 35, showing a 36.46 percent premium over the issue price.

Is Spunweb Nonwoven IPO a good investment?

Strong GMP and early subscription data indicate promising sentiment, but investors should evaluate fundamentals and risks.

What is the minimum investment required?

Investors must apply for at least one lot of 1,200 shares, totaling Rs. 2,16,000.

When will IPO allotment be finalized?

The allotment date is set for July 17, 2025.

When is the listing scheduled?

The shares are expected to list on NSE SME on July 21, 2025.

Conclusion: Final Thoughts

The Spunweb Nonwoven IPO GMP is trending for all the right reasons—strong investor interest, high subscription volume, and an impressive grey market premium. The company’s performance metrics and product relevance in fast-growing sectors like hygiene and healthcare further strengthen the IPO’s appeal. While momentum is clearly strong, it’s important for investors to make informed decisions based on their financial goals and tolerance for risk.

Stay updated and keep an eye out for listing developments. This IPO might set a new benchmark in the SME segment for 2025.